Medicare Enrolled
Dr. Raimy Amasha, MD
Student in an Organized Health Care Education/Training Program · Austin, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Amasha from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Amasha? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Amasha
Dr. Raimy Amasha is a student in an organized health care education/training program in Austin, TX, with 17 years in practice. Based on federal Medicare data, Dr. Amasha performed 4,143 Medicare services across 2,665 unique beneficiaries.
Between the years covered by Open Payments, Dr. Amasha received a total of $43,228 from 69 pharmaceutical and/or device companies across 819 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in student in an organized health care education/training program. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Amasha is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice▲ Top 4% volume in TX$ $43,228 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,143
Medicare services
Top 4% in TX for student in an organized health care education/training program
2,665
Unique beneficiaries
$114
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~244 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 1,040 | $95 | $765 |
| Drug screening test | 969 | $60 | $600 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 462 | $240 | $1,300 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 402 | $195 | $1,300 |
| Office visit, established patient (20-29 min) | 346 | $65 | $515 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 242 | $153 | $1,300 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 106 | $96 | $807 |
| New patient office visit (30-44 min) | 84 | $87 | $765 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 52 | $75 | $601 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 47 | $40 | $373 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 42 | $96 | $652 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 42 | $54 | $377 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 42 | $204 | $1,599 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 41 | $62 | $428 |
| Injection of substance into lower spine canal using imaging guidance | 34 | $78 | $713 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 27 | $106 | $761 |
| Insertion of spinal neurostimulator electrode array through skin | 25 | $246 | $2,959 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | 24 | $207 | $1,621 |
| Injection of upper or middle spine facet joint using imaging guidance, second level | 23 | $57 | $437 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | 23 | $72 | $490 |
| New patient office visit (45-59 min) | 17 | $127 | $1,165 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 15 | $71 | $1,300 |
| Fluoroscopic guidance for needle placement | 14 | $21 | $200 |
| Joint injection, major joint | 13 | $39 | $429 |
| Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming | 11 | $32 | $296 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$43,228
Total received (2018-2024)
Avg $6,175/year across 7 years
Top 1% in TX for student in an organized health care education/training program
69
Companies
819
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$25,649 (59.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$15,329 (35.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,250 (5.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,172
2023$2,836
2022$3,323
2021$6,328
2020$4,557
2019$4,835
2018$19,177
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Pernix Therapeutics Holdings, Inc.
$14,366
Abbott Laboratories
$8,777
BOSTON SCIENTIFIC CORPORATION
$2,342
Lilly USA, LLC
$2,277
Spinal Simplicity, LLC
$2,114
Nevro Corp.
$1,629
Vertiflex, Inc.
$1,385
PFIZER INC.
$770
Medinc of Texas
$764
Boston Scientific Corporation
$736
Collegium Pharmaceutical, Inc.
$622
Relievant Medsystems, Inc.
$549
AbbVie Inc.
$511
Daiichi Sankyo Inc.
$416
Medtronic, Inc.
$400
SI-BONE, INC.
$386
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$365
Biohaven Pharmaceuticals, Inc.
$356
Stimwave Technologies Incorporated
$316
Amgen Inc.
$303
Teva Pharmaceuticals USA, Inc.
$288
BioDelivery Sciences International, Inc.
$245
Scilex Pharmaceuticals Inc.
$204
Novartis Pharmaceuticals Corporation
$202
Medtronic USA, Inc.
$192
SI-BONE, Inc.
$157
ABBVIE INC.
$154
Biohaven Pharmaceutical Holding Company Ltd.
$150
AstraZeneca Pharmaceuticals LP
$136
Arbor Pharmaceuticals, Inc.
$136
ARBOR PHARMACEUTICALS, INC.
$135
Bioventus LLC
$129
AbbVie, Inc.
$110
TerSera Therapeutics LLC
$108
Allergan, Inc.
$105
Almatica Pharma LLC
$89
INSYS Therapeutics Inc
$87
SCILEX PHARMACEUTICALS INC.
$86
RedHill Biopharma Inc.
$78
PAINTEQ LLC
$77
Takeda Pharmaceuticals U.S.A., Inc.
$75
Lundbeck LLC
$74
Vertical Pharmaceuticals, LLC
$74
Horizon Therapeutics plc
$69
Purdue Pharma L.P.
$66
Forte Bio-Pharma LLC
$43
Zimmer Biomet Holdings, Inc.
$41
Egalet US Inc
$41
Nalu Medical, Inc.
$40
DePuy Synthes Sales Inc.
$38
Zyla Life Sciences, Inc.
$38
Azurity Pharmaceuticals, Inc.
$37
IBSA Pharma Inc.
$34
Shionogi Inc
$29
Assertio Therapeutics, Inc.
$29
MML US, Inc.
$29
Kyowa Kirin, Inc.
$24
Ultragenyx Pharmaceutical Inc.
$24
Baudax Bio Inc.
$20
GRT US Holding, Inc.
$18
Radius Health, Inc.
$16
ConvaTec Inc.
$16
IMPEL PHARMACEUTICALS INC.
$16
Sentynl Therapeutics, Inc.
$16
Virtus Pharmaceuticals LLC
$15
Nuvectra Corporation
$15
SPR Therapeutics, Inc
$14
Zyla Life Sciences
$14
Alnylam Pharmaceuticals Inc.
$11
Top 3 companies account for 59.0% of total payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · ANJESO · AQUACEL AG+ EXTRA · Aimovig · Algovita · Amitiza · BELBUCA · BOTOX · BUNAVAIL 2.1 mg 30-count box · Belbuca · Cambia · Crysvita · DUROLANE · Durolane · EMGALITY · ETERNA · Edarbi · FLECTOR · GELSYN-3 · GENERAL THERAPIES · GENERAL PAIN MANAGEMENT · GENERAL - PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · GIVLAARI · GRALISE · Gel One · Gel-One Cross-linked Hyaluronate · HA MINUTEMAN G3-R · HORIZANT · Horizant · IFUSE IMPLANT · INFINION · INTELLIS · INTELLIS ADAPTIVESTIM · Intracept · LEVORPHANOL TARTRATE · LICART · LORZONE · LYRICA · Levorphanol · Licart · METHYLPHENIDATE 72 · MOVANTIK · Morphabond ER · Movantik · NAPRELAN · NURTEC ODT · Nalu Neurostimulation System · Nucynta · Nucynta ER · ORTHOVISC · Octrode SCS Leads · Omnia · PAINTEQ · PENNSAID · PROCLAIM · PROLATE · Prialt · Proclaim Family of SCS IPGs · Proclaim IPG · Prodigy Family of SCS IPGs · QULIPTA · Qutenza · RELISTOR · ReActiv8 · SCS IPGs · SILENOR · SPECTRA WAVEWRITER · SPRINT PNS System · SPRIX · SUBSYS · SUPERION · SYMPROIC · SYNCHROMED · Senza · Senza II · Senza Spinal Cord Stimulation System · StimQ Peripheral Nerve StimulatorSystem · Superion · Superion ISS · Symproic · Trudhesa · Tymlos · UBRELVY · VANTA ADAPTIVESTIM · VERTECEM · VYEPTI · WAVEWRITER ALPHA · WORKMATE CLARIS · WaveWriter Alpha Prime 16 · XTAMPZA · Xtampza ER · ZIPSOR · ZOHYDRO ER · ZORVOLEX · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (59%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for student in an organized health care education/training program in TX.
Equivalent to $1,043 per 100 Medicare services performed
Geographic Context
Student in an Organized Health Care Education/Training Programs within 10 mi
787
Per 100K population
60.2
County median income
$97,169
Nearest hospital
NORTHWEST HILLS SURGICAL HOSPITAL
2.1 mi
2.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Amasha is a clinical cardiology specialist, with above-average Medicare volume (top 4% in TX), and high industry engagement (low-engagement, top 1%), with 17 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Amasha experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Amasha performed 1,040 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Amasha receive payments from pharmaceutical companies?
Yes. Dr. Amasha received a total of $43,228 from 69 companies across 819 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Amasha's costs compare to other student in an organized health care education/training programs in Austin?
Dr. Amasha's average Medicare payment per service is $114. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Amasha) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Student in an Organized Health Care Education/Training Programs in Austin
Browse student in an organized health care education/training programs in Austin ranked by procedure volume and transparency data.
Highest volume
Top Student in an Organized Health Care Education/Training Programs in TX
Student in an Organized Health Care Education/Training Programs ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Student in an Organized Health Care Education/Training Programs in TX
Which TX student in an organized health care education/training programs receive the most from drug and device companies.
By company
Pernix Therapeutics Holdings, Inc. Payments to Doctors
See all physicians who received payments from Pernix Therapeutics Holdings, Inc..
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
BOSTON SCIENTIFIC CORPORATION Payments to Doctors
See all physicians who received payments from BOSTON SCIENTIFIC CORPORATION.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology